IP Library Granted Patent US 8,580,772
Granted Patent B2
US 8,580,772 · App. 12/327,885 · Granted Nov 12, 2013

Combination therapies using melengestrol acetate and zilpaterol or its salts

Inventors: Mary Irene Wray (Desoto, KS); Damon Edward Bradley (Desoto, KS); Melissa A. Petersen (Desoto, KS); Auddie Sharp (Desoto, KS); Celia Shelton (Lewes, DE); Jayden Lloyd Montgomery (Winston-Salem, NC)
Assignee: Intervet Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,772
App. No.
12/327,885
Granted
Nov 12, 2013
Kind
B2
Abstract

This invention generally relates to a method for promoting growth and increasing feed utilization efficiency in animals, and, more specifically, to combinations comprising zilpaterol (and salts thereof) and melengestrol acetate. Included within this invention are treatment methods comprising the administration of such combinations to animals, compositions comprising such combinations, uses of such combinations to prepare medicaments, and kits for using such combinations.

Claims (21)

1. A method for improving feed utilization efficiency or increasing the rate of weight gain in an animal, wherein the method comprises administering to the animal an effective amount of zilpaterol (or a salt thereof), an effective amount of melengestrol acetate, an effective amount of monensin (or a salt thereof) and an effective amount of tylosin (or a salt thereof).

2. The method of claim 1 , wherein the amount of the zilpaterol (or salt thereof) and the amount of melengestrol acetate are, when combined, sufficient to improve the animal's average daily feed utilization efficiency over a period of at least about 3 days relative to the average daily feed utilization efficiency that would be realized by administering the amount of the zilpaterol (or salt thereof) without any melengestrol acetate over the same amount of time under otherwise substantially identical feeding conditions.

3. The method of claim 2 , wherein the amount of the zilpaterol (or salt thereof) and the amount of melengestrol acetate are, when combined, sufficient to increase the animal's average daily weight gain over a period of at least about 3 days by at least about 100% the average daily weight gain that is realized during the week immediately before administration of the zilpaterol (or salt thereof) and melengestrol acetate under otherwise substantially identical feeding conditions.

4. The method of claim 1 , wherein the amount of the zilpaterol (or salt thereof) and the amount of melengestrol acetate are, when combined, sufficient to increase the animal's average daily weight gain over a period of at least about 3 days relative to the average daily weight gain that would be realized by administering the amount of the zilpaterol (or salt thereof) without any melengestrol acetate over the same amount of time under otherwise substantially identical feeding conditions.

5. The method of claim 4 , wherein the amount of the zilpaterol (or salt thereof) and the amount of melengestrol acetate are, when combined, sufficient to increase the animal's average daily weight gain over a period of at least about 3 days by at least about 1.2 times the average daily weight gain that would be realized by administering the amount of the zilpaterol (or salt thereof) without any melengestrol acetate over the same amount of time under otherwise substantially identical feeding conditions.

6. The method of claim 1 , wherein at least a portion of the zilpaterol (or salt thereof) and at least a portion of the melengestrol acetate are administered in a single formulation.

7. The method of claim 1 , wherein at least a portion of the zilpaterol (or salt thereof) is administered in a separate formulation from at least a portion of the melengestrol acetate.

8. The method of claim 1 , wherein at least a portion of the zilpaterol (or salt thereof) or at least a portion of the melengestrol acetate is administered orally.

9. The method of claim 1 , wherein the zilpaterol (or salt thereof) and the melengestrol acetate are administered orally.

10. The method of claim 1 , wherein the method comprises administering zilpaterol hydrochloride.

11. The method of claim 1 , wherein the method further comprises administering at least one additional steroid.

12. The method of claim 1 , wherein the method further comprises administering trenbolone acetate.

13. The method of claim 1 , wherein the method further comprises administering zeranol, estradiol, or estradiol benzoate.

14. The method of claim 1 , wherein the method further comprises administering at least one ionophore.

15. The method of claim 1 , wherein the method comprises administering monensin sodium.

16. The method of claim 1 , wherein the method further comprises administering at least one antibiotic.

17. The method of claim 1 , wherein the method comprises administering tylosin phosphate or tylosin tartrate.

18. The method of claim 1 , wherein the animal is a bovine animal.

19. The method of claim 1 , wherein the animal is a swine animal.

20. The method of claim 1 , wherein the animal is a bird.

21. The method of claim 1 , wherein the animal is a fish.

Assignments (4)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
CORRECTIVE ASSIGNMENT TO CORRECT THE U.S. APPLICATION NO. 13/327,885 PREVIOUSLY RECORDED ON REEL 031315 FRAME 0437. ASSIGNOR(S) HEREBY CONFIRMS THE U.S. APPLICATION NO. 12/327,885. Recorded Oct 7, 2013
From: INTERVET INTERNATIONAL B.V.
To: INTERVET INC.
Reel/Frame 031359/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2013
From: INTERVET INTERNATIONAL B.V.
To: INTERVET INC.
Reel/Frame 031315/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2010
From: WRAY, MARY IRENE; BRADLEY, DAMON EDWARD; PETERSEN, MELISSA A.; SHARP, AUDDIE; SHELTON, CELIA; MONTGOMERY, JAYDEN LLOYD
To: INTERVET INTERNATIONAL B.V.
Reel/Frame 024109/0846 →
Continuity (2)
Provisional Application 60992922 · Dec 6, 2007
Related Publication 20090181906A1 · Jul 16, 2009